Data from Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast Cancer
Sylvia Adams(NYU Langone Health), Sandra Demaria(Cornell University), Silvia C. Formenti(Cornell University), Tsivia Hochman(NYU Langone Health), Nicholas S. Shuman(Kirtland Air Force Base), Leonard Liebes(New York University), Derya Unutmaz(Jackson Laboratory), Frank Martiniuk(Psychogenics (United States)), Luis Chiriboga(Columbia University Irving Medical Center), Nina Bhardwaj(Mount Sinai Hospital), James L. Speyer(Breast Center), Deborah Axelrod(New York University), Amy Tiersten(Icahn School of Medicine at Mount Sinai), Yelena Novik(NYU Langone Health), Judith D. Goldberg(New York University), Tze‐Chiang Meng(New York University), Lina Kozhaya(Jackson Laboratory)
Cited by 0
Related Papers
Identification of a major co-receptor for primary isolates of HIV-1
|Nature|1996|3.7k
Immunology of COVID-19: Current State of the Science
|Immunity|2020|1.8k
DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
|Nature Communications|2017|1.7k